X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gd-dota (92) 92
magnetic resonance imaging (58) 58
humans (48) 48
radiology, nuclear medicine & medical imaging (46) 46
gadolinium (44) 44
index medicus (41) 41
contrast media (40) 40
male (39) 39
animals (35) 35
magnetic resonance imaging - methods (33) 33
mri (32) 32
female (30) 30
middle aged (25) 25
adult (23) 23
contrast agents (23) 23
rats (21) 21
aged (19) 19
contrast agent (18) 18
contrast media - chemistry (17) 17
organometallic compounds (17) 17
mice (15) 15
gadopentetate dimeglumine (14) 14
contrast media - administration & dosage (13) 13
dtpa (13) 13
knee (13) 13
complexes (12) 12
contrast media - pharmacokinetics (12) 12
heterocyclic compounds (12) 12
safety (12) 12
gadolinium - chemistry (11) 11
gadolinium dtpa (11) 11
nephrogenic systemic fibrosis (11) 11
pharmacokinetics (11) 11
organometallic compounds - administration & dosage (10) 10
organometallic compounds - pharmacokinetics (10) 10
relaxivity (10) 10
aged, 80 and over (9) 9
cell line, tumor (9) 9
contrast media - adverse effects (9) 9
enhancement (9) 9
heterocyclic compounds - pharmacokinetics (9) 9
imaging / radiology (9) 9
kernspintomographie (9) 9
magnetic-resonance (9) 9
medicine & public health (9) 9
nanoparticles (9) 9
organometallic compounds - chemistry (9) 9
rheumatoid arthritis (9) 9
time factors (9) 9
tumors (9) 9
adolescent (8) 8
article (8) 8
biochemistry & molecular biology (8) 8
kontrastmittel (8) 8
magnetic resonance (8) 8
agent (7) 7
angiography (7) 7
contrast enhancement (7) 7
heterocyclic compounds - administration & dosage (7) 7
in-vivo (7) 7
pharmacology & pharmacy (7) 7
radiology & nuclear medicine (7) 7
ultrasound (7) 7
arthritis, rheumatoid - diagnosis (6) 6
cancer (6) 6
chemistry, organic (6) 6
gd-dtpa (6) 6
heterocyclic compounds - chemistry (6) 6
image enhancement - methods (6) 6
inflammation (6) 6
materials science, biomaterials (6) 6
meglumine - analogs & derivatives (6) 6
meglumine gd-dota (6) 6
organometallic compounds - adverse effects (6) 6
rabbits (6) 6
rheumatology (6) 6
stability (6) 6
young adult (6) 6
biodistribution (5) 5
cells (5) 5
chemistry, multidisciplinary (5) 5
child (5) 5
contrast media - metabolism (5) 5
diagnosis (5) 5
drug delivery systems (5) 5
drug-delivery (5) 5
gadobenate dimeglumine (5) 5
gadolinium-dtpa (5) 5
gadoterate meglumine (5) 5
gd (5) 5
gd‐dota (5) 5
image processing, computer-assisted (5) 5
injections, intravenous (5) 5
life sciences (5) 5
meglumine - adverse effects (5) 5
nanoscience & nanotechnology (5) 5
neuroradiology (5) 5
quantitative assessment (5) 5
rats, sprague-dawley (5) 5
relaxation (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biomolecular NMR, ISSN 0925-2738, 01/2014, Volume 58, Issue 1, pp. 27 - 35
Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 02/1999, Volume 9, Issue 2, pp. 348 - 352
A series of high‐generation (G) ethylenediamine‐core polyamidoamine (PAMAM) dendrimers corresponding to G = 5, 7, 9, and 10 were conjugated with the... 
Gd(DOTA) | macromolecular contrast agent | relaxometry | dendrimer | Dendrimer | Relaxometry | Macromolecular contrast agent
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 09/2019, Volume 568, p. 118496
Magnetic resonance angiography (MRA) requires the use of contrast agents (CAs) to enable accurate diagnosis. There are currently no CAs on the market with... 
Gd-DOTA | Gd-micelles | Pharmacokinetics | Blood pool contrast agents | Magnetic resonance angiography | CLEARANCE | DIAGNOSIS | COMPLEXES | GADOLINIUM DEPOSITION | PORPHYRIN | RELAXIVITY | ANGIOGRAPHY | PHARMACOLOGY & PHARMACY | AGENTS | ALBUMIN | BINDING
Journal Article
INVESTIGATIVE RADIOLOGY, ISSN 0020-9996, 12/2008, Volume 43, Issue 12, pp. 817 - 828
Journal Article
Chinese Journal of Organic Chemistry, ISSN 0253-2786, 07/2018, Volume 38, Issue 7, pp. 1779 - 1785
Journal Article
Magnetic Resonance in Medicine, ISSN 0740-3194, 03/2018, Volume 79, Issue 3, pp. 1568 - 1578
Journal Article
by Cao, LM and Li, BB and Yi, PW and Zhang, HL and Dai, JW and Tan, B and Deng, ZW
BIOMATERIALS, ISSN 0142-9612, 04/2014, Volume 35, Issue 13, pp. 4168 - 4174
Three Gd-DOTA-peptide complexes with different peptide sequence are synthesized and used as T-1 contrast agent to label human mesenchymal stem cells (hMSCs)... 
GADOLINIUM | MATERIALS SCIENCE, BIOMATERIALS | hMSCs | MRI | CONTRAST AGENTS | ENGINEERING, BIOMEDICAL | COMPLEXES | T-1 enhancement | DENDRIMERS | CANCER | Gd-DOTA-peptides | DELIVERY | Relaxivity | IN-VIVO | CONJUGATE
Journal Article
Biomaterials, ISSN 0142-9612, 11/2018, Volume 182, pp. 269 - 278
Despite the great success in clinical magnetic resonance imaging (MRI), Gd -based contrast agents still suffer from low proton relaxation efficiency, rapid... 
Transformation | MRI enhancement | Photodynamic therapy | MMP-2 | Chimeric peptide | DESIGN | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | RETENTION | DRUG-RELEASE | CANCER | NANOPARTICLES | PHARMACOKINETICS | TARGETED ACCUMULATION | GD-DOTA | IN-VIVO | MRI CONTRAST AGENTS | Peptides | Magnetic resonance imaging | Photochemotherapy | Contrast media | Cancer | Tumors
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 01/2011, Volume 21, Issue 1, pp. 303 - 306
To image gene expression in vivo, we designed and synthesized a novel signal turn-on probe for F nuclear magnetic resonance (MR) imaging based on paramagnetic... 
Gd-DOTA | Paramagnetic relaxation enhancement | Nucleic acids | 19F magnetic resonance imaging | F magnetic resonance imaging
Journal Article
Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 04/2017, Volume 45, Issue 4, pp. 988 - 997
Purpose To investigate the safety of gadoterate meglumine and identify the incidence of nephrogenic systemic fibrosis (NSF). Materials and Methods An... 
adverse event | magnetic resonance imaging | gadolinium‐based contrast agent | gadoterate meglumine | gadoteric acid | contrast media | gadolinium-based contrast agent | DIAGNOSTIC-VALUE | RISK-FACTORS | ACID | EFFICACY | CONTRAST AGENTS | MRI | GUIDELINES | GD-DOTA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SEVERITY | NEPHROGENIC SYSTEMIC FIBROSIS | Prospective Studies | Follow-Up Studies | Image Enhancement | Humans | Middle Aged | Child, Preschool | Infant | Male | Incidence | Young Adult | Contrast Media - adverse effects | Aged, 80 and over | Adult | Female | Child | Nephrogenic Fibrosing Dermopathy - epidemiology | Meglumine - adverse effects | Organometallic Compounds - adverse effects | Risk Factors | Nephrogenic Fibrosing Dermopathy - chemically induced | Europe - epidemiology | Magnetic Resonance Imaging | Asia - epidemiology | Internationality | Adolescent | Aged | Medicine, Experimental | Medical research | Nausea | Safety and security measures | Contrast media | Rodents | Creatinine | Kidneys | Identification methods | Urticaria | Central nervous system | Nervous system | Risk analysis | Patients | Risk factors | Glomerular filtration rate | Demographics | Renal insufficiency | Magnetic resonance imaging | Vomiting | Fibrosis | Adults | Children | Safety | Age | Kidney transplantation | Original Research
Journal Article
世界胃肠病学杂志:英文版(电子版), ISSN 1007-9327, 2015, Issue 19, pp. 5831 - 5842
AIM: To investigate the performance of GadofluorineP-enhanced magnetic resonance imaging (MRI) onthe diagnosis of diabetes in a streptozotocin (STZ)-induced... 
P | Gd-DOTA | 1 | Type | Magnetic | Gadofluorine | resonancecontrast | media | Pancreas | diabetes
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 13, pp. 4168 - 4174
Journal Article